The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health organization dedicated to funding blood cancer research, education and patient services. LLS's mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. Since the first funding in 1954, LLS has awarded more than $680 million in research funding.
Learn more about:
Acute monoblastic leukemia Hairy cell leukemia aplastic anemia Myelodysplastic syndromes Aplastic anemia Lymphoma- large-cell Acute myeloid leukemia small lymphocytic lymphoma Non-Hodgkin Lymphoma B-cell lymphomas Chronic lymphocytic leukemia Chronic myeloid leukemia Waldenstrom macroglobulinemia Lymphoblastic lymphoma Acute promyelocytic leukemia Non-Hodgkin lymphoma
Related Access Program
Children’s Hospital Los Angeles – Acute myeloid leukemia Jazz Pharmaceuticals – Secondary AML Seattle Genetics, Inc. – Lymphoma, Large-Cell, Anaplastic Celator Pharmaceuticals – Secondary AML Pusan National University Hospital – Chronic Myeloid Leukemia University of California, San Francisco – Chronic Myeloid Leukemia Emory University – Chronic Myeloid Leukemia University of California, San Francisco – B-cell lymphomas University of California, San Francisco – Myelodysplastic syndromes Emory University – Myelodysplastic syndromes Pusan National University Hospital – Chronic myeloid leukemia University of California, San Francisco – Chronic myeloid leukemia Pfizer – Chronic myeloid leukemia Emory University – Chronic myeloid leukemia University of California, San Francisco – Acute myeloid leukemia Emory University – Acute myeloid leukemia